CAPN7 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 2.091800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
7.724400E-01
Normal-vs-Stage2
1.179590E-01
Normal-vs-Stage3
1.511980E-01
Normal-vs-Stage4
8.835800E-01
Stage1-vs-Stage2
1.339800E-01
Stage1-vs-Stage3
3.054000E-02
Stage1-vs-Stage4
5.812200E-01
Stage2-vs-Stage3
1.375140E-04
Stage2-vs-Stage4
3.944300E-02
Stage3-vs-Stage4
7.559900E-04
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
2.316600E-01
Normal-vs-AfricanAmerican
5.198800E-01
Normal-vs-Asian
7.637600E-02
Caucasian-vs-AfricanAmerican
6.533800E-01
Caucasian-vs-Asian
1.462410E-01
AfricanAmerican-vs-Asian
1.802560E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
2.006000E-01
Normal-vs-Female
2.438200E-01
Male-vs-Female
6.292200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
8.605600E-01
Normal-vs-Age(41-60Yrs)
3.960000E-01
Normal-vs-Age(61-80Yrs)
1.649410E-01
Normal-vs-Age(81-100Yrs)
1.136840E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
5.374800E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
2.419200E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
1.163440E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
3.060300E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
8.545800E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
6.162800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
5.324400E-02
Normal-vs-Daily Drinker
3.009600E-02
Normal-vs-Weekly Drinker
1.337210E-01
Normal-vs-Occasional Drinker
3.530200E-01
Normal-vs-Social Drinker
6.495000E-01
Non Drinker-vs-Daily Drinker
6.567000E-01
Non Drinker-vs-Weekly Drinker
8.374200E-01
Non Drinker-vs-Occasional Drinker
9.360400E-02
Non Drinker-vs-Social Drinker
1.443610E-01
Daily Drinker-vs-Weekly Drinker
5.774600E-01
Daily Drinker-vs-Occasional Drinker
4.850100E-02
Daily Drinker-vs-Social Drinker
9.556100E-02
Weekly Drinker-vs-Occasional Drinker
2.528800E-01
Weekly Drinker-vs-Social Drinker
2.279800E-01
Occasional Drinker-vs-Social Drinker
6.864000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
3.842400E-01
Normal-vs-Grade 2
2.344400E-01
Normal-vs-Grade 3
6.325200E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
4.917200E-01
Grade 1-vs-Grade 3
7.681200E-01
Grade 1-vs-Grade 4
3.842400E-01
Grade 2-vs-Grade 3
4.630400E-01
Grade 2-vs-Grade 4
2.344400E-01
Grade 3-vs-Grade 4
6.325200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
6.570300E-02
Normal-vs-NonDiabetic
1.862570E-01
Diabetic-vs-NonDiabetic
5.409600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
1.080250E-01
Normal-vs-NoPancreatitis
1.809570E-01
Pancreatitis-vs-NoPancreatitis
5.748400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
4.516800E-01
Normal-vs-N1
1.179400E-01
N0-vs-N1
3.830000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
1.568380E-01
Normal-vs-TP53-NonMutant
6.749200E-01
TP53-Mutant-vs-TP53-NonMutant
4.645900E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
